Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin and BioThrax Interaction Study
NCT01753115Phase 2Completed
- Sponsor
- Emergent BioSolutions
- Start
- Dec 2012
- Primary completion
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of anthrax vaccine adsorbed in anthrax, sponsored by Emergent BioSolutions. Started Dec 2012; status: completed.
02
Drugs
anthrax vaccine adsorbed
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT01753115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753115.